Investigating miRNA-661 and ATG4-B mRNA expression as potential biomarkers for hepatocellular carcinoma
| dc.Affiliation | October University for modern sciences and Arts (MSA) | |
| dc.contributor.author | Ali M.A. | |
| dc.contributor.author | Matboli M. | |
| dc.contributor.author | El-Khazragy N. | |
| dc.contributor.author | Saber O. | |
| dc.contributor.author | El-Nakeep S. | |
| dc.contributor.author | Abdelzaher H.M. | |
| dc.contributor.author | Shafei A.E.-S. | |
| dc.contributor.author | Mostafa R. | |
| dc.contributor.other | October University for Modern Sciences and Arts | |
| dc.date.accessioned | 2020-01-09T20:40:58Z | |
| dc.date.available | 2020-01-09T20:40:58Z | |
| dc.date.issued | 2018-02-14 | |
| dc.description | SJR 2024 0.493 Q3 H-Index 59 | |
| dc.description.abstract | Aim: We aimed to examine the statistical association between serum expression of miRNA 661 (miR-661) and ATG-4B mRNA and hepatocellular carcinoma (HCC) based on in silico data analysis followed by clinical validation. Patients & methods: Quantitative reverse-transcriptase real-time PCR was used to examine the expression of miR-661 and ATG-4B mRNA in the sera of HCC patients versus control. Results: The expression of miR-661 and ATG-4B mRNA was positive in 97.14 and 77.14%, respectively, in HCC patients. The survival analysis showed that ATG-4B mRNA was an independent prognostic factor. Conclusion: Our data are the first report of its kind regarding the considerable clinical significance of miR-661 and ATG-4B mRNA in HCC patients. | en_US |
| dc.description.uri | https://www.scimagojr.com/journalsearch.php?q=11300153402&tip=sid&clean=0 | |
| dc.identifier.citation | Ali, M. A., Marwa Matboli, Nashwa El-Khazragy, Saber, O., El-Nakeep, S., Abdelzaher, H. M., Ayman El-Sayed Shafei, & Mostafa, R. (2018). Investigating MIRNA-661 and ATG4-B MRNA Expression as Potential Biomarkers for Hepatocellular Carcinoma. Biomarkers in Medicine, 12(3), 245–256. https://doi.org/10.2217/bmm-2017-0273 | |
| dc.identifier.doi | https://doi.org/10.2217/bmm-2017-0273 | |
| dc.identifier.issn | 17520363 | |
| dc.identifier.other | https://doi.org/10.2217/bmm-2017-0273 | |
| dc.identifier.uri | https://t.ly/q2rjD | |
| dc.language.iso | English | en_US |
| dc.publisher | Taylor and Francis Ltd. | en_US |
| dc.relation.ispartofseries | Biomarkers in Medicine;12(3):245-256 | |
| dc.subject | ATG-4B; bioinformatics; biomarkers; hepatocellular carcinoma; miR-661; prognosis. | en_US |
| dc.title | Investigating miRNA-661 and ATG4-B mRNA expression as potential biomarkers for hepatocellular carcinoma | en_US |
| dc.type | Article | en_US |
| dcterms.source | Scopus |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- Investigating_miRNA_661_and_ATG4_B_mRNA.pdf
- Size:
- 328.18 KB
- Format:
- Adobe Portable Document Format
